This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Keryx Biopharmaceuticals Inc (KERX)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 74.28M 55.70M 14.68M 35.25M
Receivables 882.00K 0.00 0.00 7.00K
Inventories 7.83M 0.00 0.00 0.00
Other Current Assets 4.09M 1.23M 430.00K 534.00K
Total Current Assets 98.60M 56.93M 15.11M 40.00M
Property, Plant & Equipment, Gross 2.71M 1.23M 879.00K 855.00K
Accumulated Depreciation & Depletion 1.18M 877.00K 823.00K 788.00K
Property, Plant & Equipment, Net 1.53M 349.00K 56.00K 67.00K
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 292.00K 281.00K 198.00K 209.00K
Total Non-Current Assets 5.03M 3.84M 3.46M 3.48M
Liabilities & Shareholder Equity
Total Assets 103.63M 60.77M 18.57M 43.49M
Accounts Payable 24.15M 14.00M 7.21M 8.87M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 29.31M 15.33M 8.04M 9.77M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 700.00K 0.00 0.00 0.00
Other Non-Current Liabilities 133.00K 38.00K 36.00K 2.67M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 833.00K 38.00K 36.00K 2.67M
Total Liabilities 30.14M 15.37M 8.07M 12.44M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 73.48M 45.40M 10.49M 31.05M
Common Par 93.00K 83.00K 72.00K 71.00K
Additional Paid In Capital 624.61M 485.01M 403.39M 401.22M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -550.86M -439.34M -392.61M -369.89M
Treasury Stock -357.00K -357.00K -357.00K -357.00K
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization 73.48M 45.40M 10.49M 31.05M
Total Equity 73.48M 45.40M 10.49M 31.05M
Total Liabilities & Stock Equity 103.63M 60.77M 18.57M 43.49M
Total Common Shares Outstanding 92.68M 82.64M 71.92M 71.02M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 79.95K 79.95K 79.95K 79.95K
Basic Weighted Shares Outstanding 91.00M 81.01M 71.63M 67.37M
Diluted Weighted Shares Outstanding 91.00M 81.01M 71.63M 67.37M
Number of Employees 155 41 25 29
Number of Part-Time Employees 0 0 0 0

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

KERX Keryx Biopharmaceuticals Inc

Chart of KERX

Analysts Ratings for KERX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 5 5 5
Moderate Buy 0 0 0 0
Hold 4 4 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 1 1

KERX Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs